JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tahir Yagdi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yagdi, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Yagdi, T.
Related Collections
Right arrow Electrophysiology - arrhythmias
Right arrowRelated Article

J Thorac Cardiovasc Surg 2004;127:304-305
© 2004 The American Association for Thoracic Surgery

Letter to the editor

Reply to the Editor

Tahir Yagdi, MD

Department of Cardiovascular Surgery, Ege University Medical Faculty, zmir, Turkey

The first 20% of the full text of this article appears below.

There is no consensus about the optimal dose and route of amiodarone in prophylaxis against atrial fibrillation after coronary artery bypass grafting. In most of the studies we cited in our article,1 intravenous amiodarone doses ranged from 10 mg/(kg · d) to 20 mg/(kg · d) through 2 to 8 days. Oral amiodarone doses ranged from 2.8 to 7.0 . . . [Full Text of this Article]


Related Article

Amiodarone for postoperative atrial fibrillation
Alexander Yazigi, Fadia Haddad, Samia Madi-Jebara, Ghassan Sleilaty, and Victor A. Jebara
J. Thorac. Cardiovasc. Surg. 2004 127: 304. [Extract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.